Global Brand Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Brand Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Brand Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Brand Drugs by Country/Region, 2017, 2022 & 2028

2.2 Brand Drugs Segment by Type

2.2.1 Biopharmaceutical

2.2.2 Chemistry Medicine

2.3 Brand Drugs Sales by Type

2.3.1 Global Brand Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Brand Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Brand Drugs Sale Price by Type (2017-2022)

2.4 Brand Drugs Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Other

2.5 Brand Drugs Sales by Application

2.5.1 Global Brand Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Brand Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Brand Drugs Sale Price by Application (2017-2022)

3 Global Brand Drugs by Company

3.1 Global Brand Drugs Breakdown Data by Company

3.1.1 Global Brand Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Brand Drugs Sales Market Share by Company (2020-2022)

3.2 Global Brand Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Brand Drugs Revenue by Company (2020-2022)

3.2.2 Global Brand Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Brand Drugs Sale Price by Company

3.4 Key Manufacturers Brand Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Brand Drugs Product Location Distribution

3.4.2 Players Brand Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Brand Drugs by Geographic Region

4.1 World Historic Brand Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Brand Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Brand Drugs Annual Revenue by Geographic Region

4.2 World Historic Brand Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Brand Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Brand Drugs Annual Revenue by Country/Region

4.3 Americas Brand Drugs Sales Growth

4.4 APAC Brand Drugs Sales Growth

4.5 Europe Brand Drugs Sales Growth

4.6 Middle East & Africa Brand Drugs Sales Growth

5 Americas

5.1 Americas Brand Drugs Sales by Country

5.1.1 Americas Brand Drugs Sales by Country (2017-2022)

5.1.2 Americas Brand Drugs Revenue by Country (2017-2022)

5.2 Americas Brand Drugs Sales by Type

5.3 Americas Brand Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Brand Drugs Sales by Region

6.1.1 APAC Brand Drugs Sales by Region (2017-2022)

6.1.2 APAC Brand Drugs Revenue by Region (2017-2022)

6.2 APAC Brand Drugs Sales by Type

6.3 APAC Brand Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Brand Drugs by Country

7.1.1 Europe Brand Drugs Sales by Country (2017-2022)

7.1.2 Europe Brand Drugs Revenue by Country (2017-2022)

7.2 Europe Brand Drugs Sales by Type

7.3 Europe Brand Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Brand Drugs by Country

8.1.1 Middle East & Africa Brand Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Brand Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Brand Drugs Sales by Type

8.3 Middle East & Africa Brand Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Brand Drugs

10.3 Manufacturing Process Analysis of Brand Drugs

10.4 Industry Chain Structure of Brand Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Brand Drugs Distributors

11.3 Brand Drugs Customer

12 World Forecast Review for Brand Drugs by Geographic Region

12.1 Global Brand Drugs Market Size Forecast by Region

12.1.1 Global Brand Drugs Forecast by Region (2023-2028)

12.1.2 Global Brand Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Brand Drugs Forecast by Type

12.7 Global Brand Drugs Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Brand Drugs Product Offered

13.1.3 Pfizer Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche Brand Drugs Product Offered

13.2.3 Roche Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Brand Drugs Product Offered

13.3.3 Sanofi Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Company Information

13.4.2 Johnson & Johnson Brand Drugs Product Offered

13.4.3 Johnson & Johnson Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Johnson & Johnson Main Business Overview

13.4.5 Johnson & Johnson Latest Developments

13.5 Merck & Co. (MSD)

13.5.1 Merck & Co. (MSD) Company Information

13.5.2 Merck & Co. (MSD) Brand Drugs Product Offered

13.5.3 Merck & Co. (MSD) Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Merck & Co. (MSD) Main Business Overview

13.5.5 Merck & Co. (MSD) Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Brand Drugs Product Offered

13.6.3 Novartis Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 AbbVie

13.7.1 AbbVie Company Information

13.7.2 AbbVie Brand Drugs Product Offered

13.7.3 AbbVie Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 AbbVie Main Business Overview

13.7.5 AbbVie Latest Developments

13.8 Gilead Sciences

13.8.1 Gilead Sciences Company Information

13.8.2 Gilead Sciences Brand Drugs Product Offered

13.8.3 Gilead Sciences Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Gilead Sciences Main Business Overview

13.8.5 Gilead Sciences Latest Developments

13.9 GlaxoSmithKline (GSK)

13.9.1 GlaxoSmithKline (GSK) Company Information

13.9.2 GlaxoSmithKline (GSK) Brand Drugs Product Offered

13.9.3 GlaxoSmithKline (GSK) Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 GlaxoSmithKline (GSK) Main Business Overview

13.9.5 GlaxoSmithKline (GSK) Latest Developments

13.10 Amgen

13.10.1 Amgen Company Information

13.10.2 Amgen Brand Drugs Product Offered

13.10.3 Amgen Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Amgen Main Business Overview

13.10.5 Amgen Latest Developments

13.11 AstraZeneca

13.11.1 AstraZeneca Company Information

13.11.2 AstraZeneca Brand Drugs Product Offered

13.11.3 AstraZeneca Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 AstraZeneca Main Business Overview

13.11.5 AstraZeneca Latest Developments

13.12 Bristol-Myers Squibb

13.12.1 Bristol-Myers Squibb Company Information

13.12.2 Bristol-Myers Squibb Brand Drugs Product Offered

13.12.3 Bristol-Myers Squibb Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Bristol-Myers Squibb Main Business Overview

13.12.5 Bristol-Myers Squibb Latest Developments

13.13 Eli Lilly

13.13.1 Eli Lilly Company Information

13.13.2 Eli Lilly Brand Drugs Product Offered

13.13.3 Eli Lilly Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Eli Lilly Main Business Overview

13.13.5 Eli Lilly Latest Developments

13.14 Teva

13.14.1 Teva Company Information

13.14.2 Teva Brand Drugs Product Offered

13.14.3 Teva Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Teva Main Business Overview

13.14.5 Teva Latest Developments

13.15 Bayer

13.15.1 Bayer Company Information

13.15.2 Bayer Brand Drugs Product Offered

13.15.3 Bayer Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Bayer Main Business Overview

13.15.5 Bayer Latest Developments

13.16 Novo Nordisk

13.16.1 Novo Nordisk Company Information

13.16.2 Novo Nordisk Brand Drugs Product Offered

13.16.3 Novo Nordisk Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Novo Nordisk Main Business Overview

13.16.5 Novo Nordisk Latest Developments

13.17 Allergan

13.17.1 Allergan Company Information

13.17.2 Allergan Brand Drugs Product Offered

13.17.3 Allergan Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Allergan Main Business Overview

13.17.5 Allergan Latest Developments

13.18 Takeda

13.18.1 Takeda Company Information

13.18.2 Takeda Brand Drugs Product Offered

13.18.3 Takeda Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Takeda Main Business Overview

13.18.5 Takeda Latest Developments

13.19 Boehringer Ingelheim

13.19.1 Boehringer Ingelheim Company Information

13.19.2 Boehringer Ingelheim Brand Drugs Product Offered

13.19.3 Boehringer Ingelheim Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Boehringer Ingelheim Main Business Overview

13.19.5 Boehringer Ingelheim Latest Developments

13.20 Takeda

13.20.1 Takeda Company Information

13.20.2 Takeda Brand Drugs Product Offered

13.20.3 Takeda Brand Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Takeda Main Business Overview

13.20.5 Takeda Latest Developments

14 Research Findings and Conclusion

Table 1. Brand Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Brand Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Biopharmaceutical

Table 4. Major Players of Chemistry Medicine

Table 5. Global Brand Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Brand Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Brand Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Brand Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Brand Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Brand Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Brand Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Brand Drugs Revenue by Application (2017-2022)

Table 13. Global Brand Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Brand Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Brand Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Brand Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Brand Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Brand Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Brand Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Brand Drugs Producing Area Distribution and Sales Area

Table 21. Players Brand Drugs Products Offered

Table 22. Brand Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Brand Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Brand Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Brand Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Brand Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Brand Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Brand Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Brand Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Brand Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Brand Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Brand Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Brand Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Brand Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Brand Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Brand Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Brand Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Brand Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Brand Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Brand Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Brand Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Brand Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Brand Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Brand Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Brand Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Brand Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Brand Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Brand Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Brand Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Brand Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Brand Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Brand Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Brand Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Brand Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Brand Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Brand Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Brand Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Brand Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Brand Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Brand Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Brand Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Brand Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Brand Drugs

Table 66. Key Market Challenges & Risks of Brand Drugs

Table 67. Key Industry Trends of Brand Drugs

Table 68. Brand Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Brand Drugs Distributors List

Table 71. Brand Drugs Customer List

Table 72. Global Brand Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Brand Drugs Sales Market Forecast by Region

Table 74. Global Brand Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Brand Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Brand Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Brand Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Brand Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Brand Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Brand Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Brand Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Brand Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Brand Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Brand Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Brand Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Brand Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Brand Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Brand Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Brand Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Brand Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Brand Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Pfizer Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Pfizer Brand Drugs Product Offered

Table 94. Pfizer Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Pfizer Main Business

Table 96. Pfizer Latest Developments

Table 97. Roche Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Roche Brand Drugs Product Offered

Table 99. Roche Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Roche Main Business

Table 101. Roche Latest Developments

Table 102. Sanofi Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Brand Drugs Product Offered

Table 104. Sanofi Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Sanofi Main Business

Table 106. Sanofi Latest Developments

Table 107. Johnson & Johnson Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Johnson & Johnson Brand Drugs Product Offered

Table 109. Johnson & Johnson Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Johnson & Johnson Main Business

Table 111. Johnson & Johnson Latest Developments

Table 112. Merck & Co. (MSD) Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Merck & Co. (MSD) Brand Drugs Product Offered

Table 114. Merck & Co. (MSD) Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Merck & Co. (MSD) Main Business

Table 116. Merck & Co. (MSD) Latest Developments

Table 117. Novartis Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Novartis Brand Drugs Product Offered

Table 119. Novartis Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Novartis Main Business

Table 121. Novartis Latest Developments

Table 122. AbbVie Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. AbbVie Brand Drugs Product Offered

Table 124. AbbVie Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. AbbVie Main Business

Table 126. AbbVie Latest Developments

Table 127. Gilead Sciences Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Gilead Sciences Brand Drugs Product Offered

Table 129. Gilead Sciences Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Gilead Sciences Main Business

Table 131. Gilead Sciences Latest Developments

Table 132. GlaxoSmithKline (GSK) Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. GlaxoSmithKline (GSK) Brand Drugs Product Offered

Table 134. GlaxoSmithKline (GSK) Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. GlaxoSmithKline (GSK) Main Business

Table 136. GlaxoSmithKline (GSK) Latest Developments

Table 137. Amgen Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Amgen Brand Drugs Product Offered

Table 139. Amgen Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Amgen Main Business

Table 141. Amgen Latest Developments

Table 142. AstraZeneca Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 143. AstraZeneca Brand Drugs Product Offered

Table 144. AstraZeneca Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. AstraZeneca Main Business

Table 146. AstraZeneca Latest Developments

Table 147. Bristol-Myers Squibb Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 148. Bristol-Myers Squibb Brand Drugs Product Offered

Table 149. Bristol-Myers Squibb Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Bristol-Myers Squibb Main Business

Table 151. Bristol-Myers Squibb Latest Developments

Table 152. Eli Lilly Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 153. Eli Lilly Brand Drugs Product Offered

Table 154. Eli Lilly Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Eli Lilly Main Business

Table 156. Eli Lilly Latest Developments

Table 157. Teva Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 158. Teva Brand Drugs Product Offered

Table 159. Teva Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Teva Main Business

Table 161. Teva Latest Developments

Table 162. Bayer Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 163. Bayer Brand Drugs Product Offered

Table 164. Bayer Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Bayer Main Business

Table 166. Bayer Latest Developments

Table 167. Novo Nordisk Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 168. Novo Nordisk Brand Drugs Product Offered

Table 169. Novo Nordisk Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Novo Nordisk Main Business

Table 171. Novo Nordisk Latest Developments

Table 172. Allergan Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 173. Allergan Brand Drugs Product Offered

Table 174. Allergan Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. Allergan Main Business

Table 176. Allergan Latest Developments

Table 177. Takeda Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 178. Takeda Brand Drugs Product Offered

Table 179. Takeda Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. Takeda Main Business

Table 181. Takeda Latest Developments

Table 182. Boehringer Ingelheim Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 183. Boehringer Ingelheim Brand Drugs Product Offered

Table 184. Boehringer Ingelheim Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. Boehringer Ingelheim Main Business

Table 186. Boehringer Ingelheim Latest Developments

Table 187. Takeda Basic Information, Brand Drugs Manufacturing Base, Sales Area and Its Competitors

Table 188. Takeda Brand Drugs Product Offered

Table 189. Takeda Brand Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 190. Takeda Main Business

Table 191. Takeda Latest Developments

List of Figures

Figure 1. Picture of Brand Drugs

Figure 2. Brand Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Brand Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Brand Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Brand Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Biopharmaceutical

Figure 10. Product Picture of Chemistry Medicine

Figure 11. Global Brand Drugs Sales Market Share by Type in 2021

Figure 12. Global Brand Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Brand Drugs Consumed in Hospital

Figure 14. Global Brand Drugs Market: Hospital (2017-2022) & (K Units)

Figure 15. Brand Drugs Consumed in Clinic

Figure 16. Global Brand Drugs Market: Clinic (2017-2022) & (K Units)

Figure 17. Brand Drugs Consumed in Other

Figure 18. Global Brand Drugs Market: Other (2017-2022) & (K Units)

Figure 19. Global Brand Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Brand Drugs Revenue Market Share by Application in 2021

Figure 21. Brand Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Brand Drugs Revenue Market Share by Company in 2021

Figure 23. Global Brand Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Brand Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Brand Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Brand Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Brand Drugs Sales 2017-2022 (K Units)

Figure 28. Americas Brand Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Brand Drugs Sales 2017-2022 (K Units)

Figure 30. APAC Brand Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Brand Drugs Sales 2017-2022 (K Units)

Figure 32. Europe Brand Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Brand Drugs Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Brand Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Brand Drugs Sales Market Share by Country in 2021

Figure 36. Americas Brand Drugs Revenue Market Share by Country in 2021

Figure 37. United States Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Brand Drugs Sales Market Share by Region in 2021

Figure 42. APAC Brand Drugs Revenue Market Share by Regions in 2021

Figure 43. China Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Brand Drugs Sales Market Share by Country in 2021

Figure 50. Europe Brand Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Brand Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Brand Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Brand Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Brand Drugs in 2021

Figure 64. Manufacturing Process Analysis of Brand Drugs

Figure 65. Industry Chain Structure of Brand Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles